[
  {
    "ts": "2026-01-28T08:09:28+00:00",
    "headline": "Amgen Lawsuit Over 340B Discounts Puts Pricing And Policy In Focus",
    "summary": "Sagebrush Health Services has filed a lawsuit against Amgen, alleging unlawful termination of discounted drug sales under the 340B Drug Pricing Program. The complaint claims Amgen bypassed federal protocols and limited patient access to lower cost medications for underserved communities. The case raises questions around Amgen's compliance with federal discount rules and its approach to safety net healthcare providers. For investors watching Amgen (NasdaqGS: AMGN), this case arrives with the...",
    "url": "https://finance.yahoo.com/news/amgen-lawsuit-over-340b-discounts-080928823.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "b62411ac-dd1f-36ff-9458-3f26dd29f9ee",
      "content": {
        "id": "b62411ac-dd1f-36ff-9458-3f26dd29f9ee",
        "contentType": "STORY",
        "title": "Amgen Lawsuit Over 340B Discounts Puts Pricing And Policy In Focus",
        "description": "",
        "summary": "Sagebrush Health Services has filed a lawsuit against Amgen, alleging unlawful termination of discounted drug sales under the 340B Drug Pricing Program. The complaint claims Amgen bypassed federal protocols and limited patient access to lower cost medications for underserved communities. The case raises questions around Amgen's compliance with federal discount rules and its approach to safety net healthcare providers. For investors watching Amgen (NasdaqGS: AMGN), this case arrives with the...",
        "pubDate": "2026-01-28T08:09:28Z",
        "displayTime": "2026-01-28T08:09:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ACuIXYrNeojUXbAJFhnPIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B7CQJIEa.2c0sQ0XIU66pg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-lawsuit-over-340b-discounts-080928823.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-lawsuit-over-340b-discounts-080928823.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]